Experts have discovered a mutation in SARS-CoV-2 that plays a key role in its ability to infect brain. This may help in understanding neurological symptoms & mystery of "long COVID," & could one day even lead to specific treatments to protect & clear the virus from brain 1/
Researchers discovered a series of mutations in the SARS-CoV-2 spike protein that enhanced the virus's ability to infect the brains of mice. 2/
They assessed SARS-CoV-2 evolution in the lung versus CNS of infected mice. Higher levels of viral divergence were observed in the CNS than the lung after intranasal challenge with a high frequency of mutations in the spike furin cleavage site (FCS). 3/
Looking at the genomes of viruses found in the brain compared to the lung, the researchers found that viruses with a specific deletion in spike (Furin Cleavage Site) were much better at infecting the brains of these animals. 4/
In this study, researchers infected mice with SARS-CoV-2 and sequenced the genomes of viruses that replicated in the brain versus the lung. In the lung, the spike protein looked very similar to the virus used to infect the mice. 5/
In the brain, however, most viruses had a deletion or mutation in a critical region of spike, i.e. FCS that dictates how it enters a cell. When viruses with this deletion were used to directly infect the brains of mice, it was largely repaired when it traveled to the lungs 6/
In order for the virus to traffic from the lung to the brain, it required changes in the spike protein that are already known to dictate how the virus gets into different types of cells. 7/
Researchers think this region of spike (FCS) is a critical regulator of whether or not the virus gets into the brain, and it could have large implications for the treatment and management of neurological symptoms reported by COVID-19 patients. 8/
It's still not known if #longCOVID is caused by direct infection of cells in the brain or due to some adverse immune response that persists beyond the infection. 9/
If it is caused by infection of cells in the central nervous system, this study suggests there may be specific treatments that could work better than others in clearing the virus from this compartment. 10/10
A NEW study revealed previously unrecognized complement dysregulation associated with impaired cell death and clearance of damaged cells, which may promote nonresolvable (NR) COVID-19 in patients, ultimately necessitating lung transplantation. 1/
Researchers analyzed complement activation in NR-COVID-19 lungs and its association with aberrant host autophagic response. It is the first study to comprehensively show the local presence of the components of the three pathways and regulators of complement activation 2/
The researchers are also the first to investigate the involvement of autophagic mediators as a potential mechanism underlying dysregulated complement-induced tissue damage leading to end-stage respiratory failure. 3/
Antibiotics save lives, but they also wreak havoc on the beneficial bacteria that inhabit the human gut. Innovative therapies could shield the microbiome from their effects. 1/
Researchers have genetically engineered bacteria and nutritional yeast to carry an enzyme that breaks down amoxicillin in the gut without affecting the antibiotic’s ability to fight infection elsewhere in the body. 2/
Other scientists have found that high- fibre diets allay antibiotics’ effects on the gut by changing how intestinal microbes metabolize nutrients. 3/
A NEW study showed that kids with #LongCOVID had lung injuries that correlated to specific LongCOVID symptoms and overall loss of blood flow in the lungs. In participants with longCOVID, greater lung perfusion correlated with increased chronic fatigue severity. 1/
Children and teens with #LongCOVID have significant lung abnormalities detected with an advanced form of MRI, called free-breathing phase-resolved functional lung (PREFUL) MRI. 2/
Children with post-COVID-19 symptoms are less likely to undergo chest scans for diagnosis and lung function monitoring than adults with LongCOVID. Lung perfusion, or blood flow in and out of the lungs, is difficult to detect in children. 3/
In efforts to comprehend this complex disorder, recent research on #LongCOVID has illuminated its prevalence, causes, and management techniques. Even today, studies are still investigating the long-term effects of SARS-CoV-2 infection on numerous organ systems. 1/
A review of 180 studies suggests that LongCOVID symptoms like memory problems, poor concentration, & brain fog may be driven by self-sustaining feedback loops involving vascular dysfunction, neuroinflammation & gut-brain axis disruption 2/
Recent study shows that patients with long COVID or similar conditions like ME/CFS often exhibit an enlarged hippocampus compared to healthy individuals, potentially linking brain inflammation to cognitive challenges. 3/
SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache & depression. Recent study shows that in #LongCOVID, IFN-y production persists until symptoms improve, highlighting a potential biomarker & a target for therapies 1/
The study shows that initial infection with SARS-CoV-2 triggers production of the antiviral protein IFN-γ, which is a normal reaction from the immune system. 2/
For most people, when their infection clears, COVID-19 symptoms cease and production of this protein stops, but the researchers found that high levels of IFN-γpersisted in some Long COVID patients for up to 31 months. 3/